Background and aims The full burden of the opioid epidemic on US hospitals has not been described. We aimed to es-
INTRODUCTION
Opioid overdoses are a global public health concern, with an estimated 99 000-253 000 deaths attributed to opioid overdoses world-wide in 2010 [1] . In the United States, unintentional drug overdoses are the leading cause of injury death among all individuals between 1980 and 2008 [2] . Of the 41 340 deaths by unintentional poisoning in 2011, 41% involved prescription opioid analgesics and 10% involved heroin [3, 4] . The death rates from prescription opioid analgesic-related overdoses (POD) and heroinrelated overdoses (HOD) have increased twofold from 2000 to 2014 [5] . There also appear to be racial and gender differences in the pattern of HOD and POD hospitalizations. Women have higher rates of POD admissions compared to men, while the admissions for white HOD patients increased at a faster rate than black HOD patients from 1993 to 2008 [6] .
In the larger opioid-use disorder population, recent research has also demonstrated a 64% increase in opioid-related emergency department visits and a 100% increase in opioid-related in-patient stays [7] with an associated increase in costs [8] . While US opioid-related poisoning admissions increased from 12 786 in 1999 to 27 765 in 2006 [9] and the estimated direct costs of opioid-related overdoses in 2009 were nearly $2.2 billion dollars in 2009 [10] , there are no updated trends in opioid overdose hospitalizations and their associated costs.
In this context, we sought to examine recent trends in opioid overdose-related admissions, outcomes and hospital costs and differences in admissions for POD and HOD. The aims of this study were to: (1) 
METHODS

Design
We analyzed data from the 2001-12 Nationwide Inpatient Sample (NIS). The NIS is the largest all-payer inpatient care database available in the United States. The NIS samples from the State Inpatient Databases participating in the Healthcare Cost and Utilization Project (HCUP), which is a family of health-care databases sponsored by the Agency for Healthcare Research and Quality. During the time-period examined, the NIS approximates a 20% stratified sample of discharges from US community hospitals, excluding rehabilitation and long-term acute care hospitals. As defined by the American Hospital Association, US community hospitals include 'all nonfederal, short-term (with an average length of stay less than 30 days), general, and other specialty hospitals, excluding hospital units of institutions'. Institutional Review Board exemption was granted by the Beth Israel Deaconess Medical Center.
Study sample
The NIS includes information on primary and secondary discharge diagnoses according to the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM). We included all admissions among patients aged 18 years or older admitted with a diagnosis (either primary or secondary) of heroin or opioid overdose using ICD-9-CM diagnosis codes defined previously for heroin and opioid overdoses [6, 11] . The presence of any primary or secondary ICD-9-CM diagnosis code and/or external-cause-of-injury (E-code) has been found previously to be the most sensitive for capturing drug overdoses [12] . Heroin overdose (HOD) cases were defined by ICD-9-CM code 965.01 or E-code E850.0. Prescription opioid overdose (POD) cases, which included both illicit and unintentional accidental, were defined similarly by ICD-9-CM codes 965. 
Measures
Outcome and utilization measures examined include length-of-stay (LOS), in-hospital death, disposition and cost of admission. Total hospital costs for each admission were calculated by converting total hospital charges to costs using the HCUP cost-to-charge ratio, which is based on hospital account reports from the Centers for Medicare and Medicaid Services (CMS) [13] . All hospital costs are reported in 2012 dollars, with inflation adjusted using the gross domestic product (GDP) price index from the US Department of Commerce, Bureau of Economic Analysis, with 2012 as the index base [14] .
Patient characteristics available in NIS include age, sex, race/ethnicity and primary payer. Chronic comorbidities were classified using Comorbidity Software maintained by HCUP to produce an Elixhauser Comorbidity Index score [15] . Hospital characteristics include US census region, teaching status, urban or rural location and hospital bed size. Hospital bed size was characterized as small, medium or large, based on the number of hospital beds, region and teaching status according to HCUP specifications.
Statistical analysis
Rates of HOD and POD admissions per 100 000 people in the United States were estimated from 2001 to 2012 using the overall population from US Census Bureau annual estimates for the appropriate year. Patient, hospital characteristics and outcomes are reported as means with standard errors for continuous variables and proportions for binary or categorical variables. We used analysis of variance or the χ 2 test for univariate within-group comparisons. Between-group differences were assessed using linear or logistic regression, with the inclusion of an interaction term between HOD or POD and year grouping. For presentation and ease of interpretability the study sample was divided into 3-year groups, and all univariate analyses were performed on these groupings. We then estimated separate multivariate linear or logistic regression models for the HOD and POD groups to examine the within-group relationships between outcomes and year adjusting for age, race/ethnicity, number of comorbidities and hospital region. Effect estimates (beta coefficients or odds ratios) and 95% confidence intervals (CIs) are reported. (Fig. 1) . The mean cost per admission did not change for HOD admissions during the study period, whereas the POD cost per admission increased slightly over time. In 2012, the cumulative hospital costs for all opioidrelated hospitalizations totaled $727.3 million dollars.
Outcomes
Unadjusted patient outcomes, resource utilization and costs are reported in Table 1 and adjusted outcomes are reported in Table 2 . LOS increased significantly over time for POD admissions. POD LOS was significantly, if modestly, longer than HOD LOS. Most were routine discharges to home. There were 687 HOD deaths and 2795 POD deaths during the study period. Total mortality rates during hospitalization remained stable over time, with 4.5% of HOD hospitalizations and 2.2% of POD hospitalizations resulting in death in 2012, despite the younger age and lower comorbidity burden among patients hospitalized with HOD. After adjustment, there was a small decrease in the odds of death per year in the POD group, whereas we observed no change in HOD mortality during the study period. HOD patients were twice as likely to leave against medical advice compared to POD patients.
HOD and POD patient characteristics
Selected patient and hospital characteristics are displayed in Table 3 . The mean age of HOD patients Figure 1 Total opioid overdose hospitalization costs and admissions 2001-12. HOD = heroin overdose. POD = prescription opioid overdose was younger than for POD and decreased further during the study period, while the mean age of POD patients increased. The proportion of white patients increased over time among admissions for HOD, with corresponding decreases in the proportion of black and Hispanic patients. While no changes in race/ethnicity over time occurred among admissions for POD, we observed significant differences between admissions for POD and HOD, with the former having a higher proportion of white patients. The mean number of chronic comorbidities increased among admissions for both HOD and POD. Similarly, although the primary payer for HOD admissions did not change over time, the proportion of Medicare-covered admissions for POD increased, with a corresponding decrease over the same periods in private insurance.
The hospital location and teaching status differed between admissions for POD and HOD. The majority of HOD admissions occurred in urban teaching and non-teaching hospitals and remained stable over the study period. In contrast, the hospital location/teaching status in POD admissions changed over time, with a shift towards more urban hospitals. Hospital size was similar and remained stable for both diagnoses during the study period, with more than 50% of admissions occurring in large hospitals in both groups. Hospital region for HOD admissions changed significantly during the study period, with the proportion of admissions in the Northeast region decreasing and the largest increase occurring in the Midwest. While the geographic distribution was stable among POD admissions over time, POD patients were particularly likely to be hospitalized in the South.
DISCUSSION
We report the trends in the rate, outcomes and costs for opioid overdose-related admissions in the United States from 2001 to 2012. During a 12-year study period, heroin overdose related admissions increased 1.9-fold and prescription opioid admissions increased 2.5-fold. There was a corresponding increase in the total costs for HOD admissions of 2.7-fold and 3.6-fold for POD admissions. The cost per admission for POD admissions increased during the study period, and total costs in both POD and HOD groups increased over time. Inhospital mortality did not improve over time for HOD patients, whereas there was a slight decrease in the adjusted odds of death in POD patients. Overall, HOD overdose admissions were twice as likely to lead to inhospital death compared to POD admissions.
These findings of an increasing rate of heroin and prescription opioid overdose admissions are consistent with and extend those from prior reports demonstrating the increase [6, 9] . POD patients were older, more likely to be female and to be white compared to HOD patients. Further, the primary health insurance for HOD admissions was most commonly either Medicaid or no health insurance, whereas the primary insurance was Medicare for the older patients hospitalized with POD. With regard to hospital characteristics, the majority of HOD and POD admissions occurred in large, urban teaching and non-teaching hospitals, with an increasing shift to such hospitals over time. Given the increases in both numbers of admissions and the proportion hospitalized in urban settings, large urban hospitals are at the forefront with regard to facing this aspect of the epidemic, while also exposing these institutions to a greater financial burden.
Demographics, hospital characteristics and geographic patterns differ between prescription opioid and heroin overdoses that result in hospitalizations. Our results expand upon a prior study demonstrating that HOD and POD admissions are actually interdependent by providing updated trends, patient characteristics and outcomes, as well as hospital characteristics [6] . In that study, each additional HOD increased the subsequent year's POD admission rate by a factor of 1.57, whereas each additional POD increased the rate of HOD admissions by a factor of 1.26 the following year. The recognition that the heroin and prescription opioid hospitalized patients are drawn from different but inter-related populations has important implications for interventions aimed at slowing the opioid epidemic. If an overdose hospitalization is viewed as an opportunity to change the course of addiction, potential obstacles or barriers to entry into opioid use disorder care may be anticipated based on the primary agent responsible for the overdose. For example, one in seven HOD patients 'leaves against medical advice', a rate much higher than observed in POD patients. The differences in POD and HOD patients may also be an opportunity for further examination into tailored interventions, including medication-assisted therapies or psychosocial interventions [16, 17] .
Our findings highlight the sobering downstream ramifications of the opioid epidemic. Despite increasing recognition of the opioid epidemic, in-patient mortality in opioid overdose-related hospital admissions has not changed over time. Further, 35% of HOD patients and 15% of POD patients had no insurance over the study period, which has financial ramifications upon health-care systems that are at the forefront of the epidemic.
A primary strength of this analysis is the use of large, nationally representative data, as our results are generalizable to all hospitalizations occurring in the United States. The study also has limitations. NIS is an administrative database collected from hospital administrative records, and thus there are inherent limitations to the granularity of these data. The findings we report from these data are limited to direct in-patient costs due to heroin and prescription opioid overdose-related hospitalization costs, which is only a small part of the financial burden of this epidemic. Health-care costs not captured in this analysis include health-care costs not captured in NIS, such as emergency department and out-patient visits, as well as opioid-related diagnosis not related to overdoses. Further, while the use of ICD-9-CM diagnoses for identifying heroin and prescription opioid overdoses has been demonstrated to be sensitive in capturing these events [12] , there remains the possibility of misclassification, which may lead to higher or lower estimates of the true burden of opioid overdose on US hospitalizations.
In summary, our study demonstrates a powerful trend in increasing heroin and prescription opioid overdoserelated admissions, with a massive associated increase in cumulative hospitalization costs, particularly for PODrelated hospitalizations. 
Declaration of interests
None.
